352 related articles for article (PubMed ID: 17287462)
1. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients.
Befroy DE; Petersen KF; Dufour S; Mason GF; de Graaf RA; Rothman DL; Shulman GI
Diabetes; 2007 May; 56(5):1376-81. PubMed ID: 17287462
[TBL] [Abstract][Full Text] [Related]
2. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents.
Petersen KF; Dufour S; Shulman GI
PLoS Med; 2005 Sep; 2(9):e233. PubMed ID: 16089501
[TBL] [Abstract][Full Text] [Related]
3. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.
Morino K; Petersen KF; Dufour S; Befroy D; Frattini J; Shatzkes N; Neschen S; White MF; Bilz S; Sono S; Pypaert M; Shulman GI
J Clin Invest; 2005 Dec; 115(12):3587-93. PubMed ID: 16284649
[TBL] [Abstract][Full Text] [Related]
4. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.
Petersen KF; Dufour S; Befroy D; Garcia R; Shulman GI
N Engl J Med; 2004 Feb; 350(7):664-71. PubMed ID: 14960743
[TBL] [Abstract][Full Text] [Related]
5. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.
Jacob S; Machann J; Rett K; Brechtel K; Volk A; Renn W; Maerker E; Matthaei S; Schick F; Claussen CD; Häring HU
Diabetes; 1999 May; 48(5):1113-9. PubMed ID: 10331418
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial oxidative function and type 2 diabetes.
Rabøl R; Boushel R; Dela F
Appl Physiol Nutr Metab; 2006 Dec; 31(6):675-83. PubMed ID: 17213881
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.
Morino K; Petersen KF; Shulman GI
Diabetes; 2006 Dec; 55 Suppl 2(Suppl 2):S9-S15. PubMed ID: 17130651
[TBL] [Abstract][Full Text] [Related]
8. Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes.
De Feyter HM; Lenaers E; Houten SM; Schrauwen P; Hesselink MK; Wanders RJ; Nicolay K; Prompers JJ
FASEB J; 2008 Nov; 22(11):3947-55. PubMed ID: 18653763
[TBL] [Abstract][Full Text] [Related]
9. Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients.
Lattuada G; Costantino F; Caumo A; Scifo P; Ragogna F; De Cobelli F; Del Maschio A; Luzi L; Perseghin G
Diabetologia; 2005 Apr; 48(4):741-7. PubMed ID: 15759111
[TBL] [Abstract][Full Text] [Related]
10. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes.
Szendroedi J; Schmid AI; Chmelik M; Toth C; Brehm A; Krssak M; Nowotny P; Wolzt M; Waldhausl W; Roden M
PLoS Med; 2007 May; 4(5):e154. PubMed ID: 17472434
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes mellitus and skeletal muscle metabolic function.
Phielix E; Mensink M
Physiol Behav; 2008 May; 94(2):252-8. PubMed ID: 18342897
[TBL] [Abstract][Full Text] [Related]
12. Enhanced skeletal muscle lipid oxidative efficiency in insulin-resistant vs insulin-sensitive nondiabetic, nonobese humans.
Galgani JE; Vasquez K; Watkins G; Dupuy A; Bertrand-Michel J; Levade T; Moro C
J Clin Endocrinol Metab; 2013 Apr; 98(4):E646-53. PubMed ID: 23393182
[TBL] [Abstract][Full Text] [Related]
13. Etiology of insulin resistance.
Petersen KF; Shulman GI
Am J Med; 2006 May; 119(5 Suppl 1):S10-6. PubMed ID: 16563942
[TBL] [Abstract][Full Text] [Related]
14. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.
Perseghin G; Scifo P; De Cobelli F; Pagliato E; Battezzati A; Arcelloni C; Vanzulli A; Testolin G; Pozza G; Del Maschio A; Luzi L
Diabetes; 1999 Aug; 48(8):1600-6. PubMed ID: 10426379
[TBL] [Abstract][Full Text] [Related]
15. [In-vivo 1H-MR spectroscopy: the determination of the intra- and extramyocellular lipid content depending on the insulin effect in the direct offspring of type-2 diabetics].
Brechtel K; Machann J; Jacob S; Strempfer A; Schick F; Häring HU; Claussen CD
Rofo; 1999 Aug; 171(2):113-20. PubMed ID: 10506884
[TBL] [Abstract][Full Text] [Related]
16. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
17. Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction.
De Feyter HM; van den Broek NM; Praet SF; Nicolay K; van Loon LJ; Prompers JJ
Eur J Endocrinol; 2008 May; 158(5):643-53. PubMed ID: 18426822
[TBL] [Abstract][Full Text] [Related]
18. Increased substrate oxidation and mitochondrial uncoupling in skeletal muscle of endurance-trained individuals.
Befroy DE; Petersen KF; Dufour S; Mason GF; Rothman DL; Shulman GI
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16701-6. PubMed ID: 18936488
[TBL] [Abstract][Full Text] [Related]
19. Impact of exercise training on insulin sensitivity, physical fitness, and muscle oxidative capacity in first-degree relatives of type 2 diabetic patients.
Østergård T; Andersen JL; Nyholm B; Lund S; Nair KS; Saltin B; Schmitz O
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E998-1005. PubMed ID: 16352678
[TBL] [Abstract][Full Text] [Related]
20. Reduction of non-esterified fatty acids improves insulin sensitivity and lowers oxidative stress, but fails to restore oxidative capacity in type 2 diabetes: a randomised clinical trial.
Phielix E; Jelenik T; Nowotny P; Szendroedi J; Roden M
Diabetologia; 2014 Mar; 57(3):572-81. PubMed ID: 24310562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
